Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9643320 | Archives of Psychiatric Nursing | 2005 | 5 Pages |
Abstract
This retrospective study compared the prevalence of diabetes mellitus/hyperglycemia between patients receiving treatment with clozapine (n = 24) and patients receiving treatment with depot (n = 27) neuroleptics in a Department of Veterans Affairs outpatient mental health clinic in the Mid-Atlantic region. Of the clozapine cases without a history of diabetes/hyperglycemia, 27.7% developed diabetes after initiation of clozapine. There were no new cases of diabetes/hyperglycemia in the depot group after initiation of depot neuroleptic. All patients receiving neuroleptic treatment should be monitored for changes in weight, lipid, and glucose levels so that appropriate preventive and therapeutic measures can be promptly initiated.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Marilyn J. Miller, Patricia M. Molla,